Knowledge of the number of causative loci is necessary to estimate the power of mapping studies of complex diseases. In the present article, we reexamine a theory developed by Risch and its implications for estimating the number L of causative loci affecting a complex inherited disease. We first show that methods based on Risch's analysis can produce estimates of L that are inconsistent with the observed population prevalence of the disease. We demonstrate this point by showing that the maximum-likelihood estimate for L produced by the method of Farrall and Holder for cleft lip/cleft palate data is not consistent with the prevalence under the multiplicative model. We show how to incorporate disease prevalence and develop a maximum-likelihood method for estimating L that uses the entire distribution of numbers of affected individuals in families containing an affected individual. This method avoids the potential inconsistencies of the Risch method and has greater precision. We apply our method to data on cleft lip/cleft palate and schizophrenia.
Introduction
It has become apparent that positional cloning for complex diseases is more difficult than has previously been envisioned. Recently, Altmü ller et al. (2001) conducted a comprehensive review of 101 whole-genome-scan studies of complex disease and found that only one-third of these produced significant linkages. Furthermore, few of the linkages that were significant were reproduced in other studies. The reasons for this lack of success are not clear. It is known that the power to detect linkage decreases as the number of loci affecting a disease increases, because the effect of each locus is lower on average. Therefore, having reliable estimates of the numbers of loci that affect complex diseases will help with the design of mapping studies.
At present, only one class of methods, based on the theory introduced by Risch (1990a) , is available to estimate the number of loci, L, when genotype data for affected individuals are unavailable. In the present article, we will reexamine Risch's theory and related theories, with the goal of developing a method for providing more-accurate estimates of the number of causative loci than are currently available. In doing so, we will show that Risch's theory may be inconsistent with the data to which it is applied, meaning that, for some models, no combination of parameter values can account for observed prevalences and relative risks. We show a method that avoids this inconsistency and has greater precision than previous methods based on Risch's theory. Risch (1990a) modeled a disease affected by loci that act either multiplicatively or additively, and he derived relationships between the relative risk of a disease in relatives with different degrees of relatedness ("l R " in his notation) as a function of the number of causative loci. He then used his theory to explore the dependence of relative risk on the number of causative loci, L. In two companion articles (Risch 1990b (Risch , 1990c , he examined the power to detect linkage in affected pairs of relatives under the additive and multiplicative models. Risch showed that the power to detect linkage to a locus depends on the relative risk attributable to that locus and that the power deteriorates quickly as L increases. Farrall and Holder (1992) extended Risch's (1990a) theory and developed a maximum-likelihood method for the estimation of L under the multiplicative model. Farrall and Holder (1992) applied their method to data from a study of cleft lip/cleft palate (CLCP) and found that the 1-LOD support interval for the number of loci was very broad: 2rϱ.
In the present article, we will first reexamine the relationship between the number of loci affecting a complex disease, the population frequency of the disease, and the relative risks, and we will show that estimates of the number of loci in a multiplicative model obtained from relative risks may be inconsistent with the observed prevalence of a disease. We will then introduce a new method for estimating the number of loci that avoids these inconsistencies and that, in two examples, gives more-precise estimates of the number of causative loci. We call this method-a form of complex segregation analysis-a "multiplex method," because it is based on the entire distribution of numbers of affected individuals in families containing an affected individual. Our analysis is similar to that of Smith (1971) , who derived recurrence risk formulas for groups of sibs and compared fits of single-locus and multifactorial threshold models. We extend Smith's recurrence risk formulas to allow for multiplicative interactions among loci and to permit analysis of other groups of relatives. We then develop a maximum-likelihood estimator for the number of disease loci. We illustrate the use of our method by applying it to CLCP data previously analyzed by Farrall and Holder (1992) and schizophrenia data published by Hovatta et al. (1997) .
The Risch Method
First, we will review Risch's (1990a) theory. Take X and as indicator variables denoting the affected status of X R the proband and a type R relative. Then, the probability is given by P(X p 1FX p 1)
R K
where K is the population prevalence of the disease and is the genetic covariance between type R relatives. C R Rearranging equation (1), we get
R 2 K where , the "relative risk," is given by P( l X p R R )/K. The relative risks for two different types 1FX p 1 of relatives R and T are given by
The above relationships apply for a single locus. Under a multiplicative penetrance model with no gametic disequilibrium, the overall relative risk is given by the product of the individual locus risks:
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Assuming that equation (3) holds for each locus and substituting into equation (4), we get
where L is the number of loci and , , and are the C C C 1 2 3 locus-specific covariances for first-, second-, and thirddegree relatives, respectively. Throughout the present article, the phrase "relative risk" refers to the total relative risk unless specified as "single-locus relative risk." Under the assumption that dominance variance is negligible, the relationship holds, and
equation (5) has a particularly simple form:
Risch (1990a) used equations (4) and (6) to compare different models of inheritance for schizophrenia. Risch also considered additive and genetic heterogeneity models. He showed that the genetic heterogeneity model is well approximated by the additive model and that the additive model gives the same pattern of relative risk as a single-locus model does. Risch (1990a) noted that, in many cases, relative risk decreases more rapidly with relatedness than is predicted by the additive model but that the multiplicative model can be parameterized to provide an approximate fit to observations. We will employ the multiplicative model here because of its mathematical simplicity and because, in the absence of other knowledge, it is reasonable. It remains to be established how realistic the multiplicative model is or what its relationship is to more-general models of epistatic interactions. Risch (1990a) employed an informal approach for the comparison of inheritance models. Farrall and Holder (1992) introduced a method using equation (6) as the basis for a maximum-likelihood method for the estimation of L under the assumption of equal contribution to disease risk by all loci. We will refer to these methods jointly as the "Risch-Farrall-Holder" (RFH) method, and we will refer to the maximum-likelihood method as the "Farrall-Holder" (FH) method. In both cases, we are referring to the method for the inference of parameters of a model of inheritance, as opposed to the relationships given by equations (1)-(6).
Inconsistency of RFH Method with Observed Population Prevalences
We will now show that the best-fit (either formal or informal) models given by the RFH method are often inconsistent with the observed population prevalence of the disease. Several authors (Suarez et al. 1976; Craddock et al. 1995; Rybicki and Elston 2000) have explored the mathematical limits on the range of possible relative-risk values under different genetic models. Craddock et al. (1995) have described a graphical method for the determination of plausible modes of inheritance for complex traits and have applied it to bipolar disorder; they showed that the lower limit on possible sib-relative-risk values for bipolar disorder is not conl S sistent with a single-locus model or any genetic heterogeneity model but that multiplicative models with three or more loci are plausible. Recently, Rybicki and Elston (2000) have studied the relationship between sib relative risk and genotype relative risk for one-and two-locus models; they looked at upper bounds on sib relative risk and showed that it is restricted to values !10 for many genetic models unless there is significant dominance. is treated as an independent parameter. However, l 1 we note that is itself dependent on L. Thus, the use l 1 of equation (5) implicitly assumes that, for every L, there is some combination of penetrance values and disease-allele frequencies that gives . We now show l 1 that this is not always true.
We will assume that all disease-predisposing alleles at a locus have equal affect. Thus, we must track only two allele types: disease-causing and non-disease-causing alleles (hereafter referred to as "disease alleles" and "nondisease alleles," respectively). Although this is less general than in Risch's (1990a) study, this case is of sufficient importance to illustrate the point. Take p as the probability that the lowest-penetrance genotype (individuals homozygous for the nondisease allele on every locus) is affected and d as the probability that the highestpenetrance genotype (individuals homozygous for the disease alleles on every locus) is affected. If we assume equal contribution to disease penetrance by all loci, then the single-locus contributions to are ,
and the single-locus contributions to are . If
we introduce a dominance coefficient h, then the three single-locus penetrance contributions are given by , p L , and , for nondisease-allele homozy-
gotes, heterozygotes, and disease-allele homozygotes, respectively. The genetic model is completely specified by a choice of L, h, p, d, and disease-allele frequency p. Thus, as L is varied in the application of the RFH method, it is (implicitly) assumed that there exist values of , , h, and p p d that will yield . If dominance variance is negligible, then l 1 parent-offspring and sib genetic covariances are equal. In this case, the parent-offspring and sib relative risks are also equal. Because this is observed for most complex diseases, it is usually assumed that there is no dominance variance, and, thus, h is restricted to regions where this is approximately true. We will use this assumption and constrain parameter values in the following analysis (but not in the application of our method in the "Multiplex Relative Risk" section, below).
In appendix A, we derive equations for the probability that a disease affects an individual given that some collection of relatives is affected. We can use this procedure to find the joint probability that parent and offspring are both affected:
where , p is the disease-allele fre-
quency, and is the parent-offspring relative risk. This l po equation gives parent-offspring risk directly, in terms of the genetic model, and is therefore fully consistent with all parameters. In addition to satisfying equation (7), the set of parameters must also produce the correct disease prevalence K, given by
Furthermore, these parameters must satisfy , 0 ! p ! 1 , and . Our goal is to find the max-0 р p р K Kр d р 1 imum value of given equations (7) and (8) and these l po constraints. We solve equation (8) for p and substitute into equation (7). This gives an expression for that l po is constrained to allow the observed disease prevalence K. The prevalence is assumed to be known exactly. Given the large sample sizes typical for prevalence, this should usually be reasonable. The dependence that this expression has on the parameters is complex and is further complicated by the somewhat vague requirement that dominance variance be negligible. In appendix B, we derive expressions for the maximum value for l po , and , and we show that, when 
.
When h is restricted to 0.5 (no dominance), we can get a simple formula (eq. [B7]) for the allowable values of . Figure 1 shows a plot of allowable values of l po as a function of L for and .
Points below the curves are allowable combinations of L and . In this case, the limits on allowable values of l 1 are very stringent. For example, schizophrenia could l po not involve more than two loci in this case. As L increases, the disease-allele frequency also increases, and it takes substantial dominance to get large relative-risk values.
The reason that the range of values of relative risk is restricted is that the prevalence K determines the disease-allele frequency for a given set of parameters. In the absence of this constraint, the relative risk simply increases with L-the more loci that are necessary for the disease, then the more important potential identityby-descent (IBD) sharing with an affected relative is for the occurrence of the disease. However, if the prevalence is accounted for, L cannot be increased without an increase in p. Figure 2a shows plots of p versus L, obtained by solving equation (8) for p. We see that p increases rapidly with L. If L increases, then the number of "disease events" that must occur for an individual to be affected also increases. Thus, the probability of a disease event must increase to keep K constant. The relative risk, in turn, has a strong dependence on p. Figure 2b shows plots of sib relative risk versus L for values of ranging from 0 to 0.2 (with p h p 0.5 L and ). As expected, the highest relative risks oc-
. At , the relative risk decreases
L p 10 creases from near 0 to near 0.6. The relationship is more complicated for (meaning that some singlep 1 0 L locus disease events occur without disease genotypes). Then, the disease-allele frequency increases less rapidly with L, because it is possible for some of the L required disease events to occur without any disease alleles. Increasing L has two opposing effects on the relative risk: the number of required disease events increases (tending to increase relative risk), but the probability of those disease events also increases (tending to decrease relative risk). The value of determines which effect dominates; p L thus, it is possible for relative risk to either increase or decrease with L (see fig. 2b ). Note, from figure 2b, that the maximum possible sib relative risk always decreases with L.
The shape of the curves in figure 2 is strongly dependent
Figure 2
Effect of varying L. a, Effect of number of loci L on disease-allele frequency p. The curves correspond to values of the dominance coefficient h, as shown, and to , , and We should stress that table 1 and figure 1 are valid only for loci of equal effect under a multiplicative model. Obviously, there are more ways to satisfy the parameter constraints when the loci can vary independently. However, the general patterns still hold. For example, a popular model for genetic epidemiological studies assumes one or a few major genes and many minor genes. A simple extension of the methods used in the present article for a disease with
shows that such a model is K p 0.01 possible only for multiplicatively interacting loci if (i) the major gene (or genes) has h near 0.5, (ii) there are у20 of the minor genes, and (iii) the minor genes have parameters very near , , and .
Environmental Correlations and Ascertainment Bias
Relative-risk values are a measure not only of genetic similarity but also of environmental similarity (Guo 2000 (Guo , 2002 . Thus, the observed values will often be inflated beyond the genetic-effect-only values assumed in Risch's (and our) method. The presence of environmental correlation will cause the estimate for L to be biased downward. Even with no environmental correlations, relativerisk estimates are subject to ascertainment bias (Rice et al. 1982; Guo 1998; Cordell and Olson 2000; Olson and Cordell 2000) . Such bias can occur for a variety of reasons, including a greater probability of the detection of families with more affected members, variations in the probability that affected individuals have children, reluctance of parents of an affected individual to have further children, and an increased probability that relatives of an affected individual are falsely diagnosed as affected. Although there are definite problems with data on recurrence risk even for first-degree relatives, the need to use data on second-and third-degree relatives in the RFH method magnifies the problem. An important advantage of our method is that it does not require data from multiple types of relatives. Thus, relatives with known or suspected bias in affected probabilities can be eliminated from the analysis. We will show, in our examples, that estimates from our method are fairly robust to variations in which relative types are included in the analysis.
Multiplex Relative Risk
We estimate L by using a maximum-likelihood approach. The likelihood function F is a product of multinomial
Figure 3
Aunt-nephew relative risk as a function of L for a parent-offspring relative risk of 10. This curve was generated by equation (5) with and
distributions for the number of affected relatives of probands:
In equation (9) Precision of Methods Figure 3 shows a plot of equation (5) In view of these arguments, we would expect that, if fits to a model are based on simple relative-risk values by using equations (5) and (7), only loose upper and lower bounds on L would be obtained. The distribution of numbers of affected sibs provides additional information. For example, figure 4 shows the probability that two of three and three of three sibs of a proband are affected when L is in the range of 3-10. Their absolute and relative values vary substantially over this range. Estimates of these multiplex probabilities for families of various sizes provide additional information about the range of L values that is most important. However, we also see, from these figures, that the probabilities of having two or more affected sibs are quite small. The probabilities in figure 4 are conditioned on the proband's being affected. We multiply by the prevalence (0.01 in the case of fig. 4 ) to get the marginal probabilities. Thus, sample sizes will need to be large to have enough such families to appreciably affect the likelihood functions.
Applications to Data

CLCP
We apply our method to one of the data sets used by Farrall and Holder (1992) . Farrall and Holder (1992) used equation (5) as a basis for a maximum-
Figure 4
Effect of number of disease loci on multiplex-disease probabilities. a, Probability that two of three sibs of an affected individual are also affected. b, Probability that three of three sibs of an affected individual are also affected. Both curves were generated with , K p 0.01 , , and .
likelihood approach to estimating L for CLCP. We will reanalyze the data of Carter et al. (1982) , which provide sufficient information to estimate the multiplex probabilities. Farrall and Holder (1992) combined data from the Carter et al. study with data from other studies from which multiplex probabilities cannot be estimated. We recompiled the data given by Carter et al. (1982) to get the probabilities that 0, 1, 2, and so forth, relatives of a proband with CLCP were affected (data for first-degree relatives are given in tables 2 and 3; similar tables for second-degree relatives are available at Paul Schliekelman's Web site). Carter et al. (1982) ; expected values were calculated from the best-fit model of , , , and . (Farrall and Holder 1992) . a Relative-risk data from an English study of CLCP (Bear 1976; Carter et al. 1982) . Following the procedure of Farrall and Holder (1992) , we assumed that there was no dominance variance and combined all relatives of the same degree together. Numbers in parentheses are sample sizes.
b Relative-risk values calculated for the best-fit model of 22 loci with equal contribution to disease risk. MLE p maximum-likelihood estimate. on shown in figure 1 apply and none of the best-fit l po models given by Farrall and Holder (1992) are compatible with the observed prevalence. Figure 5a shows the likelihood profile for L obtained using multiplex relative risk. In all likelihood plots, the likelihood value shown is the maximum across all parameters not shown. We see a strong peak in the likelihood in the range of , with the likelihood L p 3-6 dropping off quickly both as L decreases to 1 and as L increases beyond 10. The likelihood then begins increasing again beyond 14 and continues increasing as L goes to 100 and beyond. Figure 5b shows a contour plot of likelihood versus L and h and helps to clarify these peaks. The contours show combinations of L and h with likelihoods 1/2, 1/10, and 1/100 of the maximum-likelihood values. We see that there are two distinct peaks in the likelihood, one at with h being higher (but L p 3 a range of 0.2-1 falling in the 1-LOD support interval) and one at with h being restricted to values L у 100 around 0. A model with у100 disease loci does not seem plausible, so this higher peak appears to be an artifact. If we dismiss it from consideration, then we find that our best-fit-value model has , , ,
, that is only slightly below the L p 6 peak. Including the actual values of the risk (as opposed to just the relative values between different degrees of relatedness) substantially increases the sensitivity of the likelihood function to L and is the major cause of the increase in precision. The number of families with more than two affected individuals is quite small for the CLCP sample sizes. The exclusion of such data from the analysis had only a minor effect on the likelihood function. The addition of first cousins also had very little effect on the likelihood profile, other than shifting the maximum-likelihood-estimate value from the to the value. L p 3 L p 6 Tables 2 and 3 show the numbers of affected firstdegree relatives predicted by the best-fit model from the multiplex method, along with the observed values. The predicted values fit the data well. However, there does appear to be a slightly higher incidence of families with more than one relative of the proband affected. Similar tables for second-degree relatives are available at Paul Schliekelman's Web site.
Application to Finnish Schizophrenia Data
To further demonstrate the utility of our method, we will also apply it to schizophrenia data. Hovatta et al. (1997) identified all cases in Finland with a diagnosis of schizophrenia and published the number of affected sibs in families (nearly 20,000) with up to 15 sibs (the data set used in our analysis is available at Paul Schliekelman's Web site). We applied the multiplex method to these data. The best-fit value was with a support interval of L p 3 [2,3], and , , and . Hovatta et al. (1999) conducted a genomewide scan for schizophrenia genes in a genetic isolate of Finland and found evidence for linkage at four loci. Thus, our results for the entire Finnish population are roughly compatible with this finding.
For this data set, we get a very tight support interval for L. Because there are substantial numbers of families with more than one relative affected, the use of multiplex data in our fitting procedure makes a substantial difference in precision. Results were essentially the same when families with more than four sibs were excluded from the data. However, the exclusion of smaller family sizes resulted in different best-fit values and a major loss of precision (i.e., support intervals of 2rϱ for L).
We also see much tighter bounds on h, , and . set, there is nothing that constrains sib and parent-offspring risks such that they are similar. The best-fit model does predict substantially different risks for parent-offspring pairs and sibs of probands, which is not consistent with other data on schizophrenia. We added 5,000 simulated parent-offspring pairs to the data, to test the importance of not having parent-offspring data. These pairs were assigned the same relative risk as observed for sib pairs in the data set. This is consistent with other data on schizophrenia (Risch 1990a) . The best-fit model (see table 5 ) had significant changes only in the dominance coefficient h, which became 1. Thus, the model fits were robust to this lack of data. However, it is clear that some parent-offspring data are needed to get correct estimates of h.
The best-fit model for CLCP had L p 3 and p 0.05. p L Thus, a person with no disease alleles would have p 0.000125 probability of being affected; this com-3 0.05 pares to 0.001 for a randomly chosen individual. For the best-fit schizophrenia model, the disease probability for an individual with no disease alleles is ; 4 0.15 p 0.0005 this compares to 0.01 for a randomly chosen individual. In contrast, both best-fit models had . This indid p 1 L cates no environmental variation in the contribution from a locus homozygous for the disease allele. In this case, an individual homozygous for the disease allele on all loci is always disease affected. Both disease models were quite robust to variation from . d p 1
L
Discussion
As shown by Risch (1990b) , the power of mapping studies for complex traits is dependent on the number of causative loci. Altmü ller et al. (2001) compared characteristics of various mapping studies in an attempt to determine which factors lead to occurrence of significant linkage; they found that sib relative risk was uncorrelated with detection of significant linkage, and they concluded that, contrary to the results of Risch (1990b) , sib relative risk is not a strong indicator of power in these studies. However, Altmü ller et al. (2001) neglected an important point: the power to detect significant linkage in a study of affected pairs of relatives depends not on the overall relative risk but on the relative risk attributable to each locus and on how the loci interact (Risch 1990b ). Thus, we do not expect to see a strong correlation between the observed relative risk and the power.
Because of the importance of contributions from each locus, methods for estimating the number of causative loci will be important for the design of mapping studies a Parameter fits with data from Hovatta et al. (1997) .
b Five thousand offspring parent-offspring pairs with relative risk equal to that for a single sib were added to the data. This was to force a realistic value of h. (Risch 1990b (Risch , 1990c . We have shown here that caution must be used in the application of the methods of Risch (1990a) and Farrall and Holder (1992) . Our analysis has shown that the application of these methods can give results that are inconsistent with the observed disease prevalence. The maximum possible parent-offspring relative risk decreases rapidly as the number of loci underlying the disease increases, and the RFH method does not constrain it to feasible values. The multiplex method introduced here is a generalization of the RFH method and is guaranteed to give consistent results. We have also shown that the precision of inference of L on the basis of the RFH method is of major concern. Often, this method can say nothing more than that the number of causative loci is 11. The multiplex method has improved precision. For the CLCP example, which had sample sizes on the order of a few hundred families, our method yielded a support interval of [2, 14] , compared with [2,ϱ] for the RFH method. Although this is not as good as we might like, [2,14] is a much more useful bound than [2,ϱ] . Our method yielded a very precise (i.e., [2, 3] ) estimate with the much larger sample size (∼20,000 families) of the schizophrenia data. For higher (greater than ∼10) best-fit values of L, the precision of the method decreases. The support intervals in such cases generally extend to infinity on the upper end and a maximum of 10-15 on the lower end (P.S., unpublished data). This tendency is due to the phenomenon illustrated in figure 2 : under a multiplicative model, the variation at individual loci becomes small as L becomes larger. Thus, there is little change in patterns of inheritance with greater numbers of loci. Although preci-sion does decrease as the best-fit L increases, the multiplex method still has better performance than the RFH method: knowing that L is 110 is much more useful than knowing only that it is 12.
As pointed out by an anonymous reviewer, some disease loci are known for some complex diseases. Thus, what is unknown is how many disease loci remain, as opposed to the total number. If the relative-risk value attributable to a known locus can be determined, then it can be divided out of the overall relative risk under a multiplicative model. The method described here can then be applied to the remaining loci.
Ascertainment Bias and Environmental Correlation
Fits of L in the applications in the present article were robust to variations in which data were included in the analysis. This indicates that it is possible to perform the analysis on subsets of available data and thus exclude suspect data. In cases in which it is not possible to exclude all biased data, it may be possible to include only data biased in the same direction. For example, data that are biased toward higher relative risks will tend to produce lower estimates of L. In this case, one could still get a lower bound on L and an upper bound on power in mapping studies. The RFH method requires data from individuals of at least two different degrees of relatedness.
Penetrance Models and Power of Mapping Studies
For CLCP and schizophrenia, the best-fit models had three and four loci, respectively. On the basis of the power relationships in Risch's (1990b Risch's ( , 1990c ) studies, affected-sib-pair studies for both these diseases should then have 80% power for sample sizes of ∼200 (assuming for CLCP and for schizophrenia l p 30 l p 10
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and marker density such that the recombination fraction is ∼0 between marker and disease allele). For CLCP, the support interval for L extended up to 14. In this case, sample sizes of у1,000 would be required in order to achieve reasonable power. It is unknown, however, how reasonable the assumption of equal contribution from all loci is. Under that assumption, the estimated value of L leads to a lower bound on the contribution from each locus. This then indicates what sample sizes and marker densities will be necessary to map causative loci (Risch 1990b (Risch , 1990c . From the point of view of mapping, assumption of equal effects is conservative. Variation among loci will ensure that at least one causative locus will have an effect greater than the lower bound. Recently, Pritchard (2001) modeled the evolution of complex-disease loci. He showed that, because of intrinsic variability in allele frequencies created by genetic drift, mutation, and, possibly, weak purifying selection, contributions of different loci would be expected to vary substantially because of variation across loci in the frequencies of causative alleles. On this basis, he argued that a higher number of loci is likely for complex diseases, since the evidence from affected-sib-pair studies is against any single locus's having a major effect. Although Pritchard's (2001) analysis was based on specific population genetic assumptions, his conclusion that substantial variation of effects across loci is to be expected is almost certain to be correct for a much wider class of models than he considered. It would be possible to incorporate variation across loci into our multiplex method. A statistical distribution (e.g., a gamma distribution) of effects could be assumed, or a population genetic model of the kind used by Pritchard (2001) could be analyzed. In either case, the resulting model might be so rich in parameters as to be impractical.
As with all model fitting, the information that we get is only as good as the model. It is completely unknown whether a multiplicative model is in any way representative of reality. It is the case that a multiplicative model can match the available risk data for CLCP and schizophrenia quite well. Using the methods outlined in the present article, we can gain much information about the implications if a multiplicative model is the correct description for a disease. However, there is no way of knowing whether a different model is more appropriate. Future work should extend the present methodology to more-general penetrance models. The primary obstacle to overcome is the large number of genotype probabilities that must be calculated when the assumption of multiplicative interactions does not apply. The popularity of multiplicative penetrance models is based on nothing more than mathematical convenience. Thus, it is important to move beyond such models. Although it is impossible to ever prove that a model is correct by using only family-history data, we can exclude models. One major success of the RFH method is showing that a model with additive action between loci is not plausible for either schizophrenia (Risch 1990a) or CLCP (Farrall and Holder 1992) . Future work should test other penetrance models and decide on their plausibility and, if they are plausible, the implications thereof.
Appendix A Derivation of Probabilities of Affected Status
Our goal is to derive equations that give the probability that M of N relatives of an affected individual are affected. We will demonstrate the derivation for two sibs of the affected individual. The derivation is similar for other types and numbers of relatives.
Take X, , and as indicator variables representing the affected status of the proband and sibs 1 and 2, X X S1 S2
respectively. These indicator variables have a value of 0 when the individual is unaffected and a value of 1 when the individual is affected. Then, is the probability that the sibs 1 and 2 are affected,
given that the proband is affected. We can expand this probability to include the parental genotypes:
where and represent the genotypes of the parents of the three sibs.
B B
1 2
Using the Bayes theorem, we can rewrite the conditional probability of the parental genotypes as
The genotype distributions of sibs are independent, given the parental genotype. Thus, the probabilities that sibs 1 and 2 are affected are independent, given the parental genotype. Hence, we have
. Finally, the genotype distribution of the parents is also
assumed to be independent. Then, equation (A1) becomes ( )
The probability of being affected given the parental genotype is the same for all children. Thus, we can write equation (A2) as
Equation (A3) can easily be extended to any number of sibs:
Next, we need the probability that an individual is affected given his or her parent's genotypes. We expand this probability in terms of the individual's genotype A, as follows:
Multiplicative Penetrance
To proceed, we need to further specify the penetrance model. Following Risch (1990a), we assume a multiplicative model for penetrance:
, where is the disease penetrance for multilocus genotype
G and is the contribution to the penetrance from the one-locus genotype on locus j. Thus, G is a vector
If there is no linkage disequilibrium, then the probability that n sibs of a proband are affected can be expressed as 
shows that the single-locus genotype frequencies can be calculated independently and then can be multiplied to get the overall probabilities.
Probabilities That Fewer Than All Sibs Are Affected
The probability that sib 1 is affected and sib 2 is unaffected is
This can be generalized as
n and so forth. Equations (A6)-(A8) are not specific to sibs and apply to any type (or combination of types) of relatives.
Appendix B Derivation of Constraints on L
Our goal is to find, given L, the maximum parent-offspring relative risk that can be produced by an allowable combination of penetrance values and allele frequencies. This risk is given by the equation
This is subject to the constraint that the parameters and allele frequencies must produce the correct disease prevalence K:
We have not found any general analytic proof on maximums for . However, we can argue, on intuitive grounds, l po that it should be maximized at and : the relative risk should be highest when disease risk is determined
completely by genotype and has no environmental component. Numerical evidence supports this. If we assume that this is the case, then we can show that will always be maximized at either or (the proof of l h p 0 h p 1 po this is straightforward, but algebraically intense and will not be shown here). We can easily find the maximums for in these cases. l po If the disease alleles are completely recessive ( ), then an affected parent must be homozygous for the disease h p 0 allele on all disease loci. Thus, it is certain that a child will receive a disease allele on each locus from that parent. We have not specified anything about the other parent. Therefore, the probability that this child receives a disease allele on a particular locus from that parent is simply the disease-allele frequency p. The probability that he or she receives the disease allele on all L loci is . The disease prevalence is given by . Then, for sibs. Each parent of an affected person must be carrying at least one disease allele on each locus. At a particular locus, another child of those parents has a one-fourth chance of inheriting both of those alleles, a one-half chance of inheriting one of them, and a one-fourth chance of inheriting neither of them. In all cases, an allele that is not IBD with one that was inherited by the affected sib has the same frequency distribution as an allele selected from the general population. Thus, we have If the parent is a heterozygote-probability -then the child has a one-half chance of getting the disease 2p(1 Ϫ p) allele on a given locus from that parent and has a (1/2)p chance of getting the normal allele from that parent and a disease allele from the other parent. If the parent is homozygous for the disease allele-probability -2 p then the child always has a "disease event" for that locus. For completely dominant disease alleles, we have . This can easily be solved for p and can be substituted into equation (B2 fig. 2 ). When p is large, the probability of being homozygous for the disease allele at a given locus is large for everyone in the population, and sharing disease alleles IBD with a sib does not make much difference. For large values of L (such that the difference between and is negligible), the maximum allowable value will be given by equation (B1 
The disease prevalence is given by
If we take and simultaneously solve equations (B3) and (B4) for and , then we get
There are other solutions to equations (B5) and (B6) with the signs of the second terms reversed, but it can be shown that these solutions give values that are not bound between 0 and 1, as required for a probability. If we apply the restrictions and , then we can get the condition 
